Olokizumab plus methotrexate: safety and efficacy over 106 weeks of treatment. Feist E, Fleischmann RM, Fatenejad S, Bukhanova D, et al. Ann Rheum Dis 2024;83:1454-1464.

Read + Share

Amedeo Smart

Independent Medical Education

Feist E, Fleischmann RM, Fatenejad S, Bukhanova D, et al. Olokizumab plus methotrexate: safety and efficacy over 106 weeks of treatment. Ann Rheum Dis 2024;83:1454-1464.
PMID: 38955475